Contineum Therapeutics (CTNM) Stock Chart & Stock Price History $10.22 -0.13 (-1.21%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Contineum Therapeutics Stock Price Performance 5 Day Performance-8.59%1 Month Performance-29.37%3 Month Performance-40.30%6 Month Performance-51.77%Year-To-Date Performance-30.24% Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address CTNM Stock Chart for Thursday, January, 30, 2025 CTNM Chart by TradingView Contineum Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/29/2025$10.47$10.35-1.15%$10.87$10.2264,338 shs$266.80 million01/28/2025$10.78$10.47-2.88%$10.80$10.4650,695 shs$269.92 million01/27/2025$11.18$10.78-3.58%$11.30$10.7634,761 shs$277.91 million01/24/2025$11.28$11.18-0.89%$11.62$11.1444,394 shs$288.22 million01/23/2025$11.21$11.28+0.62%$11.48$11.0857,895 shs$290.80 million01/22/2025$11.28$11.21-0.62%$11.76$11.1554,927 shs$288.99 million01/21/2025$12.44$11.28-9.32%$12.53$11.2562,463 shs$290.80 million01/20/2025$12.44$12.44$12.76$12.29102,138 shs$320.68 million01/17/2025$12.48$12.44-0.32%$12.76$12.29102,138 shs$320.70 million01/16/2025$12.96$12.48-3.70%$13.31$12.1957,102 shs$321.71 million Get the Latest News and Ratings for CTNM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 01/15/2025$12.77$12.96+1.49%$13.57$12.8570,295 shs$334.11 million01/14/2025$13.23$12.77-3.48%$13.40$12.5788,125 shs$329.21 million01/13/2025$13.29$13.23-0.45%$13.38$12.95154,390 shs$341.04 million01/10/2025$13.37$13.29-0.60%$13.57$12.82164,442 shs$342.59 million01/09/2025$13.37$13.37$13.62$12.99198,448 shs$344.65 million01/08/2025$13.77$13.37-2.90%$13.62$12.99198,448 shs$344.65 million01/07/2025$14.22$13.77-3.16%$14.90$13.6594,024 shs$354.96 million01/06/2025$14.52$14.22-2.07%$15.25$14.1560,594 shs$366.56 million01/03/2025$14.48$14.52+0.28%$14.70$13.7255,114 shs$374.30 million01/02/2025$14.65$14.48-1.16%$15.02$14.2576,346 shs$373.27 million01/01/2025$14.65$14.65$14.97$13.94111,179 shs$377.65 million12/31/2024$14.47$14.65+1.24%$14.97$13.94111,179 shs$377.65 million12/30/2024$14.40$14.47+0.49%$14.54$13.9870,797 shs$373.01 million Related Companies COLL Stock Chart NTLA Stock Chart SYRE Stock Chart GYRE Stock Chart ELVN Stock Chart ZYME Stock Chart ABCL Stock Chart RCKT Stock Chart ETNB Stock Chart AVBP Stock Chart Receive CTNM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Contineum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CTNM) was last updated on 1/30/2025 by MarketBeat.com Staff From Our PartnersHot Stock Alert! Biotech innovator on the NYSE announces breakthrough antiviral therapyA revolutionary antiviral drug is here! This breakthrough could mean viruses are unlikely to escape treatment....Smallcaps Daily | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredIs Big Tech dead?China just threw a “$5.5 million” curveball called Deep Seek to Silicon Valley and the timing of it is no coin...Brownstone Research | SponsoredAlert: DOGE goes live"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what ...Altimetry | SponsoredDonald Trump is about to free crypto from its chains …On October 25th, Juan said Bitcoin would cross $100,000 before the inauguration. Now he thinks it could rea...Weiss Ratings | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredPlease take this warning seriously...I’m here to issue a stark warning to you about an unexpected $2 trillion shock that could impact every trader ...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Contineum Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Contineum Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CTNM Stock Alerts